Cytosorbents Corp expected to post a loss of 14 cents a share - Earnings Preview
12/03/2024 21:13
* Cytosorbents Corp CTSO.OQ CTSO.O is expected to show a
fall
in quarterly revenue when it reports results on March 14 for
the period ending December 31 2023
* The Princeton New Jersey-based company is expected to
report a
1.1% decrease in revenue to $9.285 million from $9.39 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Cytosorbents Corp is for
a
loss of 14 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Cytosorbents Corp
is $4.00, above its last closing price of $1.04.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.15 -0.14 -0.21 Missed -52.2
Jun. 30 2023 -0.11 -0.11 -0.14 Missed -24.4
Mar. 31 2023 -0.13 -0.13 -0.17 Missed -34.2
Dec. 31 2022 -0.18 -0.17 -0.02 Beat 88.1
Sep. -0.16 -0.16 -0.28 Missed -70.7
30 2022
Jun. 30 2022 -0.14 -0.13 -0.25 Missed -86.9
Mar. 31 2022 -0.12 -0.12 -0.21 Missed -71.4
Dec. 31 2021 -0.17 -0.13 -0.21 Missed -58.6
This summary was machine generated March 12 at 21:13 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)